“Increasing Adoption of Drug-Eluting Bio-Absorbable Stents”
A key trend in the bio-absorbable stent market is the growing preference for drug-eluting bio-absorbable stents. These stents are designed to release therapeutic agents, reducing the risk of restenosis while gradually dissolving after serving their purpose. Their ability to improve vascular healing and avoid long-term complications associated with permanent stents has driven their adoption. For instance, Abbott’s Absorb GT1 Bioresorbable Vascular Scaffold System has gained significant attention for offering drug-eluting properties alongside complete absorption by the body over time. This trend aligns with the broader shift toward advanced, patient-centered medical technologies, bolstering market growth, especially in regions with high incidences of coronary artery disease.
